SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.
Ehrenhöfer-Wölfer K, Puchner T, Schwarz C, Rippka J, Blaha-Ostermann S, Strobl U, Hörmann A, Bader G, Kornigg S, Zahn S, Sommergruber W, Schweifer N, Zichner T, Schlattl A, Neumüller RA, Shi J, Vakoc CR, Kögl M, Petronczki M, Kraut N, Pearson MA, Wöhrle S.
Ehrenhöfer-Wölfer K, et al. Among authors: sommergruber w.
Sci Rep. 2019 Aug 12;9(1):11661. doi: 10.1038/s41598-019-48152-x.
Sci Rep. 2019.
PMID: 31406271
Free PMC article.